Overview
Mark Wrona is a Palliative Medicine provider in Portsmouth, New Hampshire. Dr. Wrona is rated as an Experienced provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Opioid Induced Constipation, Upper Tract Urothelial Carcinoma (UTUC), Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
155 Borthwick Ave, Suite C, Portsmouth, NH 03801
2 Independence Dr, Kennebunk, ME 04043
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Sarah Slater is a Palliative Medicine specialist and a Hematologist in Boston, Massachusetts. Dr. Slater is rated as an Advanced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Pancreatic Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, and Prostate Cancer. Dr. Slater is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Douglas Brandoff is a Palliative Medicine specialist and a Hematologist in Boston, Massachusetts. Dr. Brandoff is rated as an Advanced provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Familial Colorectal Cancer, and Familial Prostate Cancer. Dr. Brandoff is currently accepting new patients.
The General Hospital Corporation
Lauren Dias is a Hematologist Oncology specialist and an Oncologist in Danvers, Massachusetts. Dr. Dias is rated as a Distinguished provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Gallbladder Adenocarcinoma. Dr. Dias is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Opioid Induced ConstipationDr. Wrona isAdvanced. Learn about Opioid Induced Constipation.
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Ampullary CancerDr. Wrona isExperienced. Learn about Ampullary Cancer.
- Classical Hodgkin LymphomaDr. Wrona isExperienced. Learn about Classical Hodgkin Lymphoma.
- Gallbladder AdenocarcinomaDr. Wrona isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gastroesophageal Junction CancerDr. Wrona isExperienced. Learn about Gastroesophageal Junction Cancer.
- Marginal Zone Lymphoma (MZL)Dr. Wrona isExperienced. Learn about Marginal Zone Lymphoma (MZL).